glp 1 agonist and dementia Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease GLP-1R agonists protect against Alzheimer's

2 The central nervous system effects of GLP-1-RA lead to delayed gastric emptying causing earlier satiety and decreased appetite

DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway

Use of antihyperglycemic drugs and risk of cancer in patients with diabetes

Clinicians should also screen for eating disorders or mood changes, since the psychosocial effects (positive or negative) of pharmacologic weight loss in youth are not yet fully understood (43)

J Mol Endocrinol (2020) 64(2):10313

Within the Hallmarks of Aging framework, their effects are most evident across metabolic, inflammatory, and mitochondrial pathways that connect cellular stress to systemic dysfunction